Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

Background: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. Objective: To describe the use of sonidegib in a large number of patients and provide more data...

Full description

Bibliographic Details
Main Authors: O.M. Moreno-Arrones, S. Béa-Ardebol, F. Mayo-Martinez, G. Pérez-Pastor, I. Torres-Navarro, M. Bonfill-Ortí, G. Deza, V. Ruiz-Salas, E. Masferrer, C. Feal, L. Turrión-Merino, A. Toll, M. Yébenes, S. Galiano-Mejías, A. Jaka, C. Ferrandiz-Pulido, A. Florez, N. Hernández-Hernández, R. Fernández-de-Misa, L. Rios-Buceta, O. Sanmartin
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Actas Dermo-Sifiliográficas
Subjects:
Neoplasias cutáneas
Oncología cutánea
Terapia dermatológica
Oncología
Online Access:http://www.sciencedirect.com/science/article/pii/S0001731023003186

Internet

http://www.sciencedirect.com/science/article/pii/S0001731023003186

Similar Items